NOV Inc. (NYSE:NOV) shareholders have incurred further losses as the stock declined 3.2% this week, taking three-year losses to 20%. Despite the company's 11% revenue growth over the past three years, the share price drop is attributed to a decrease in earnings per share and a decline in investor sentiment. The TSR for the last three years is -20%, largely due to dividend payments.
NOV Inc. (NYSE:NOV) shareholders have experienced further losses this week, with the stock declining by 3.2%. This latest drop brings the company's three-year total return to negative 20%. Despite the company's 11% revenue growth over the past three years, the share price drop is primarily attributed to a decrease in earnings per share and a decline in investor sentiment
Raymond James Financial Inc. Grows Holdings in NOV Inc. $NOV[1].
NOV Inc. reported a quarterly earnings per share (EPS) of $0.29, falling short of the consensus estimate of $0.30. The company's revenue for the quarter was $2.19 billion, slightly exceeding analyst expectations. However, the stock's performance has been negatively impacted by a decrease in EPS and a decline in investor confidence
Raymond James Financial Inc. Grows Holdings in NOV Inc. $NOV[1].
The company's three-year total return (TSR) of -20% is largely due to dividend payments. NOV Inc. declared a quarterly dividend of $0.075 per share, yielding 2.3%, with an ex-dividend date set for September 12th. The company's dividend payout ratio is currently 24.59%
Raymond James Financial Inc. Grows Holdings in NOV Inc. $NOV[1].
Several large institutional investors have recently modified their holdings in NOV Inc. Raymond James Financial Inc. increased its holdings by 18.0% in the first quarter, owning 269,293 shares valued at approximately $4.1 million. Other notable investors include Mirae Asset Global Investments Co. Ltd., Exchange Traded Concepts LLC, GAMMA Investing LLC, Vanguard Group Inc., and Envestnet Asset Management Inc.
Raymond James Financial Inc. Grows Holdings in NOV Inc. $NOV[1].
The company's stock has been the subject of various research reports. Analysts have generally lowered their price objectives and ratings for NOV Inc. JPMorgan Chase & Co. lowered their rating from "overweight" to "neutral" and lowered their price objective from $17.00 to $15.00. Morgan Stanley also lowered their price objective from $18.00 to $15.00 and set an "overweight" rating for the company. Other analysts have provided mixed ratings, with seven analysts assigning a "Buy" rating, eight a "Hold" rating, and three a "Sell" rating
Raymond James Financial Inc. Grows Holdings in NOV Inc. $NOV[1].
Despite the recent declines, NOV Inc. remains focused on its growth strategies. The company is expanding its engineering capabilities and focusing on quantum sensing technologies, which are expected to drive future performance
Earnings call transcript: Frequency Electronics Q1 2025 sees revenue decline[2].
Comments
No comments yet